Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it.

Smith TG, Castro KM, Troeschel AN, Arora NK, Lipscomb J, Jones SM, Treiman KA, Hobbs C, McCabe RM, Clauser SB.

Cancer. 2016 Feb 1;122(3):344-51. doi: 10.1002/cncr.29767. Epub 2015 Nov 30.

2.

Using patient-reported outcome measures as quality indicators in routine cancer care.

Stover AM, Basch EM.

Cancer. 2016 Feb 1;122(3):355-7. doi: 10.1002/cncr.29768. Epub 2015 Nov 30. No abstract available.

3.

Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment.

Given B, Given C, Azzouz F, Stommel M.

Nurs Res. 2001 Jul-Aug;50(4):222-32.

PMID:
11480531
4.

The National Cancer Institute Community Cancer Centers Program (NCCCP): Sustaining Quality and Reducing Disparities in Guideline-Concordant Breast and Colon Cancer Care.

Spain P, Teixeira-Poit S, Halpern MT, Castro K, Prabhu Das I, Adjei B, Lewis R, Clauser SB.

Oncologist. 2017 Aug;22(8):910-917. doi: 10.1634/theoncologist.2016-0252. Epub 2017 May 9.

5.

Improving quality of cancer care at community hospitals: impact of the National Cancer Institute Community Cancer Centers Program pilot.

Halpern MT, Spain P, Holden DJ, Stewart A, McNamara EJ, Gay G, Das IP, Clauser S.

J Oncol Pract. 2013 Nov;9(6):e298-304. doi: 10.1200/JOP.2013.000937. Epub 2013 Aug 13.

6.

Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.

Kent EE, Malinoff R, Rozjabek HM, Ambs A, Clauser SB, Topor MA, Yuan G, Burroughs J, Rodgers AB, DeMichele K.

J Am Geriatr Soc. 2016 Jan;64(1):186-92. doi: 10.1111/jgs.13888.

PMID:
26782871
7.

Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial.

Velthuis MJ, May AM, Koppejan-Rensenbrink RA, Gijsen BC, van Breda E, de Wit GA, Schröder CD, Monninkhof EM, Lindeman E, van der Wall E, Peeters PH.

BMC Cancer. 2010 Jun 9;10:272. doi: 10.1186/1471-2407-10-272.

8.

Core state preconception health indicators - pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009.

Robbins CL, Zapata LB, Farr SL, Kroelinger CD, Morrow B, Ahluwalia I, D'Angelo DV, Barradas D, Cox S, Goodman D, Williams L, Grigorescu V, Barfield WD; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2014 Apr 25;63(3):1-62.

9.

Integrating the use of patient-reported outcomes for both clinical practice and performance measurement: views of experts from 3 countries.

Van Der Wees PJ, Nijhuis-Van Der Sanden MW, Ayanian JZ, Black N, Westert GP, Schneider EC.

Milbank Q. 2014 Dec;92(4):754-75. doi: 10.1111/1468-0009.12091.

10.

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E; National Cancer Institute PRO-CTCAE Study Group.

JAMA Oncol. 2015 Nov;1(8):1051-9. doi: 10.1001/jamaoncol.2015.2639. Erratum in: JAMA Oncol. 2016 Jan;2(1):146.

12.

Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.

Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS, Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G; National Cancer Institute.

J Clin Oncol. 2007 Nov 10;25(32):5051-7. Review.

13.

Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients.

Hollen PJ, Msaouel P, Gralla RJ.

Breast Cancer Res Treat. 2015 Jun;151(3):679-86. doi: 10.1007/s10549-015-3420-5. Epub 2015 May 17.

PMID:
25981897
14.

CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.

Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2014 Oct 31;63(4):3-27.

PMID:
25356673
15.

Pain, psychological distress, health status, and coping in patients with breast cancer scheduled for autotransplantation.

Gaston-Johansson F, Ohly KV, Fall-Dickson JM, Nanda JP, Kennedy MJ.

Oncol Nurs Forum. 1999 Sep;26(8):1337-45.

PMID:
10497773
16.

Health-related quality of life in early breast cancer.

Groenvold M.

Dan Med Bull. 2010 Sep;57(9):B4184.

PMID:
20816024
17.

Cancer-related fatigue: implications for breast cancer survivors.

Berger AM, Gerber LH, Mayer DK.

Cancer. 2012 Apr 15;118(8 Suppl):2261-9. doi: 10.1002/cncr.27475. Review.

18.

Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials.

Donovan KA, Donovan HS, Cella D, Gaines ME, Penson RT, Plaxe SC, von Gruenigen VE, Bruner DW, Reeve BB, Wenzel L.

J Natl Cancer Inst. 2014 Jul 8;106(7). pii: dju128. doi: 10.1093/jnci/dju128. Print 2014 Jul. Review.

19.

Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis.

Sieper J, Kivitz A, van Tubergen A, Deodhar A, Coteur G, Woltering F, Landewé R.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1475-80. doi: 10.1002/acr.22594.

20.

Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.

Quinten C, Maringwa J, Gotay CC, Martinelli F, Coens C, Reeve BB, Flechtner H, Greimel E, King M, Osoba D, Cleeland C, Ringash J, Schmucker-Von Koch J, Taphoorn MJ, Weis J, Bottomley A.

J Natl Cancer Inst. 2011 Dec 21;103(24):1851-8. doi: 10.1093/jnci/djr485. Epub 2011 Dec 7.

Supplemental Content

Support Center